Clinical trial · Observational
Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
Multicenter Study of Tibial Dysplasia in Neurofibromatosis Type I (NF1) Patients
NCT00303368CI-TRIAL-00037260NF1TDcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is a multicenter four-year outcome study of the natural history of tibial dysplasia in patients with NF1 and selected patients without NF1. We will obtain information on the natural history, burden, functional and health status, health-related quality of life, and surgical interventions/outcomes of tibial dysplasia. The project will also establish a Core Facility (NOCF) for tissue samples for future studies.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neurofibromatosis Type 1 | — | UNRESOLVED | — |
| Tibial Dysplasia | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Aim 1: * Group 1, NF1 with Tibial Dysplasia, Ages: 3-18 * Group 2 (control), NF1 without Tibial Dysplasia, Ages 3-18 * Aim 2: NF1 with Tibial Dysplasia, 19+ * Aim 3: Tibial Dysplasia with or without NF1, Ages: birth to 18 * Tissue procurement, any participant undergoing surgery at the tibial site for routine standard of care Exclusion Criteria: * Patients without a diagnosis of NF1 or Tibial Dysplasia
References
Publications (0)
Data not yet available
No reference posted for this study.